Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL Zanubrutinib versus bendamustine and rituximab in untreated patients with CLL/SLL February 2025 Clinical trials Read more
2022 May Clinical trials Utomilumab improves the efficacy of CAR-T cell therapy for advanced large B-cell lymphoma Read more
2022 May Science Adolescent and young adult males with sickle cell disease often unaware of fertility issues Read more
2022 May Clinical trials Promising results with rilzabrutinib for patients with immune thrombocytopenia Read more
Top
